Jeffrey Tyner

2002–2025 年に発表

103
論文数
18,023
被引用数
64
h 指数
102
i10 指数

被引用数

Jeffrey Tyner の年別被引用数1975 年: 被引用 1 件1988 年: 被引用 1 件2001 年: 被引用 1 件2002 年: 被引用 2 件2003 年: 被引用 2 件2004 年: 被引用 7 件2005 年: 被引用 7 件2006 年: 被引用 19 件2007 年: 被引用 38 件2008 年: 被引用 48 件2009 年: 被引用 69 件2010 年: 被引用 60 件2011 年: 被引用 91 件2012 年: 被引用 124 件2013 年: 被引用 126 件2014 年: 被引用 131 件2015 年: 被引用 114 件2016 年: 被引用 92 件2017 年: 被引用 129 件2018 年: 被引用 135 件2019 年: 被引用 505 件2020 年: 被引用 600 件2021 年: 被引用 617 件2022 年: 被引用 732 件2023 年: 被引用 608 件2024 年: 被引用 1,136 件2025 年: 被引用 465 件2026 年: 被引用 15 件1976〜1987 年は被引用が無いため表示していません1989〜2000 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,485 件、この内訳の 29%中国: 引用元論文 946 件、この内訳の 11%イギリス: 引用元論文 539 件、この内訳の 6.3%ドイツ: 引用元論文 528 件、この内訳の 6.2%イタリア: 引用元論文 479 件、この内訳の 5.6%フランス: 引用元論文 384 件、この内訳の 4.5%カナダ: 引用元論文 255 件、この内訳の 3%オーストラリア: 引用元論文 232 件、この内訳の 2.7%スペイン: 引用元論文 219 件、この内訳の 2.6%日本: 引用元論文 215 件、この内訳の 2.5%オランダ: 引用元論文 198 件、この内訳の 2.3%スイス: 引用元論文 194 件、この内訳の 2.3%
0%29%その他 22%

分野

  • Medicine64.4%
  • Biochemistry, Genetics and Molecular Biology25.2%
  • Immunology and Microbiology6.7%
  • Computer Science1.5%
  • Chemistry0.6%
  • Neuroscience0.4%
  • その他1.2%

トピック

  • Acute Myeloid Leukemia Research11.8%
  • Chronic Myeloid Leukemia Treatments4.9%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment4.4%
  • Chronic Lymphocytic Leukemia Research3.8%
  • Protein Degradation and Inhibitors2.8%
  • Acute Lymphoblastic Leukemia research2.6%
  • その他69.7%

共著者

全論文

検索で開く
  1. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joop H. Jansen, Rashmi Kanagal‐Shamanna, Hagop M. Kantarjian, Christian P. Kratz, Xiaoqiu Li, Megan S. Lim, Keith R. Loeb, Sanam Loghavi, Andrea N. Marcogliese, Soheil Meshinchi, Phillip Michaels, Kikkeri N. Naresh, Yasodha Natkunam, Reza Nejati, German Ott, Eric Padron, Keyur P. Patel, Nikhil Patkar, Jennifer Picarsic, Uwe Platzbecker, Irene Roberts, Anna Schuh, William A. Sewell, Reiner Siebert, Prashant Tembhare, Jeffrey Tyner, Srđan Verstovšek, Wei Wang, Brent L. Wood, Wenbin Xiao, Cecilia C.S. Yeung, Andreas Hochhaus - Leukemia 2022 被引用: 3,904

  2. Functional genomic landscape of acute myeloid leukaemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jason Glover, Rachel Henson, Hibery Ho, Abdusebur Jemal, Kara Johnson, Ryan C. Johnson, Brian Junio, Andy Kaempf, Jessica Leonard, Chenwei Lin, Selina Qiuying Liu, Pierrette Lo, Marc Loriaux, Samuel B. Luty, Tara A. Macey, Jason D. MacManiman, Jacqueline Martinez, Motomi Mori, Dylan Nelson, Ceilidh Nichols, Jill Peters, Justin Ramsdill, Angela Rofelty, Robert Schuff, Robert P. Searles, Erik Segerdell, Rebecca L. Smith, Stephen E. Spurgeon, Tyler Sweeney, Aashis Thapa, Corinne Visser, Jake Wagner, Kevin Watanabe‐Smith, Kristen Werth, Joelle Wolf, Libbey White, Amy Yates, Haijiao Zhang, Christopher R. Cogle, Robert H. Collins, Denise C. Connolly, Michael W. Deininger, Leylah Drusbosky, Christopher S. Hourigan, Craig T. Jordan, Patricia Kropf, Tara L. Lin, Micaela Martínez, Bruno C. Medeiros, Rachel R. Pallapati, Daniel A. Pollyea, Ronan Swords, Justin M. Watts, Scott J. Weir, David L. Wiest, Ryan M. Winters, Shannon K. McWeeney, Brian Druker - Nature 2018 被引用: 1,476

  3. Integrative analysis of drug response and clinical outcome in acute myeloid leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stuart Hagler, Heath Harrelson, Rachel Henson, Hibery Ho, Sunil K. Joshi, Brian Junio, Andy Kaempf, Yoko Kosaka, Ted Laderas, Matt Lawhead, Hyun-Jung Lee, Jessica Leonard, Chenwei Lin, Evan Lind, Selina Qiuying Liu, Pierrette Lo, Marc Loriaux, Samuel B. Luty, Julia E. Maxson, Tara A. Macey, Jacqueline Martinez, Jessica Minnier, Andrea Monteblanco, Motomi Mori, Quinlan Morrow, Dylan Nelson, Justin Ramsdill, Angela Rofelty, Alexandra Rogers, Kyle A. Romine, Peter Ryabinin, Jennifer N. Saultz, David A. Sampson, Samantha L. Savage, Robert Schuff, Robert P. Searles, Rebecca L. Smith, Stephen E. Spurgeon, Tyler Sweeney, Ronan Swords, Aashis Thapa, Karina Thiel-Klare, Elie Traer, Jake Wagner, Beth Wilmot, Joelle Wolf, Guanming Wu, Amy Yates, Haijiao Zhang, Christopher R. Cogle, Robert H. Collins, Michael W. Deininger, Christopher S. Hourigan, Craig T. Jordan, Tara L. Lin, Micaela Martínez, Rachel R. Pallapati, Daniel A. Pollyea, Anthony D. Pomicter, Justin M. Watts, Scott J. Weir, Brian Druker, Shannon K. McWeeney, Jeffrey Tyner - Cancer Cell 2022 被引用: 368

  4. The TP53 Apoptotic Network Is a Primary Mediator of Resistance to BCL2 Inhibition in AML Cells

    著者: , , , , , , , , , , , , , , , - Cancer Discovery 2019 被引用: 366

  5. AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2009 被引用: 1,247

  6. Integrated analysis of patient samples identifies biomarkers for venetoclax efficacy and combination strategies in acute myeloid leukemia

    著者: , , , , , , , , , - Nature Cancer 2020 被引用: 203

  7. Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia

    著者: , , , , , , , , , , , , , - Cell Reports 2017 被引用: 270

  8. Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2019 被引用: 245

  9. An expanded universe of cancer targets

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew L. Kung, Brent R. Stockwell, Jesse S. Boehm, Josh Dempster, Robert T. Manguso, Francisca Vázquez, Lee Cooper, Yuhong Du, Andrei A. Ivanov, Sagar Lonial, Carlos S. Moreno, Qiankun Niu, Taofeek K. Owonikoko, Suresh S. Ramalingam, Matthew A. Reyna, Wei Zhou, Carla Grandori, Ilya Shmulevich, Elizabeth M. Swisher, Jitong Cai, Issac S. Chan, Matthew Dunworth, Yuchen Ge, Dan Georgess, Eloïse M. Grasset, Elodie Henriet, Hildur Knútsdóttir, Michael G. Lerner, Veena Padmanaban, Matthew C. Perrone, Yasir Suhail, Yohannes Tsehay, Manisha Warrier, Quin Morrow, Tamilla Nechiporuk, Nicola Long, Jennifer N. Saultz, Andy Kaempf, Jessica Minnier, Cristina E. Tognon, Stephen E. Kurtz, Anupriya Agarwal, Jordana F. Brown, Kevin Watanabe‐Smith, Tania Q. Vu, Thomas Jacob, Yunqi Yan, Bridget A. Robinson, Evan Lind, Yoko Kosaka, Emek Demir, Joseph Estabrook, Michael Grzadkowski, Olga Nikolova, Ken Chen, Ben Deneen, Han Liang, Michael C. Bassik, Asmita Bhattacharya, Kevin Brennan, Christina Curtis, Olivier Gevaert, Hanlee P. Ji, Kasper Karlsson, Kremena Karagyozova, Yuan‐Hung Lo, Katherine Liu, Michitaka Nakano, Anuja Sathe, Amber R. Smith ほか 25 名 - Cell 2021 被引用: 224

  10. The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistance

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Brian Druker, Elie Traer - Cancer Cell 2021 被引用: 147

  11. Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma

    著者: , , , , , , , , , , , , , , , , , - Gut 2016 被引用: 235

  12. Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia

    著者: , , , , , , , , , , , , , , , , , - Blood Advances 2022 被引用: 92

  13. Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2019 被引用: 151

  14. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease

    著者: , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2008 被引用: 524

  15. Tracking the Evolution of Therapy-Related Myeloid Neoplasms Using Chemotherapy Signatures

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gareth J. Morgan, Ola Landgren, Francesco Maura - Blood 2023 被引用: 37

  16. CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability

    著者: , , , , , , , , , , , , , - Blood 2010 被引用: 718

  17. Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas Radimerski, Arend von Stackelberg, Cornelia Eckert, Jeffrey Tyner, Péter Horváth, Beat Bornhäuser, Jean‐Pierre Bourquin - Blood 2017 被引用: 260

  18. The ITIM-containing receptor LAIR1 is essential for acute myeloid leukaemia development

    著者: , , , , , , , , , , , , , - Nature Cell Biology 2015 被引用: 137

  19. Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 109

  20. OncogenicCSF3RMutations in Chronic Neutrophilic Leukemia and Atypical CML

    著者: , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2013 被引用: 563

  21. CSF1R inhibitors exhibit antitumor activity in acute myeloid leukemia by blocking paracrine signals from support cells

    著者: , , , , , , , , , , , , , , , , - Blood 2018 被引用: 108

  22. Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2021 被引用: 93

  23. AZD4320, A Dual Inhibitor of Bcl-2 and Bcl-xL, Induces Tumor Regression in Hematologic Cancer Models without Dose-limiting Thrombocytopenia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ricky W. Johnstone, Eric T. Gangl, Martin Wild, Michael Zinda, J. Paul Secrist, Barry R. Davies, Stephen E. Fawell, Francis D. Gibbons - Clinical Cancer Research 2020 被引用: 69

  24. FGF2 from Marrow Microenvironment Promotes Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia

    著者: , , , , , , , , , - Cancer Research 2016 被引用: 165